With revenue potential of Rs 600 cr
Gold Price Today: Gold dips Rs 1,000/10 gm this week so far while silver tumbles Rs 4,300/kg (09-10-2024)
Gold and silver futures contracts opened with slight changes on MCX today as traders booked profits. The market is reacting to potential de-escalation in the Middle East and anticipated U.S. inflation data. Gold December futures are slightly down, while silver December futures are up. Market volatility is expected to continue due to these factors.
Transformer & Rectifier India Limited (09-10-2024)
Premature. Also, isn’t Cohesion MK Best ideas also MKela? Appears under FII holdings.
Taking TRIL results + Q2concall into account – we are witnessing a mammoth turnaround and if the management continues to execute, FY27 could be mind-numbing.
Holding tight – once in a lifetime opportunity for the company, and shareholders.
Hot Stocks: Brokerage view on HDFC Bank, SBI and IGL (09-10-2024)
CLSA maintains a hold rating on HDFC Bank with a target price of Rs 1,725, while Nomura and Citi have buy ratings for SBI and IGL, respectively. HDFC Bank faces a dilemma akin to Shakespeare’s Hamlet, choosing to sell down loans to address its high loan-deposit ratio, though this approach may not effectively repair its balance sheet and comes at the cost of profits.
Silver price today: Trend bearish; check key support, resistance levels (09-10-2024)
Silver price today: Silver prices crashed to their lowest level since September 19, on Tuesday, as commodities tumbled on multitude of bearish developments
Alembic Pharma rises after oncology facility completes US FDA audit with ‘zero’ observations (09-10-2024)
Alembic Pharmaceuticals added 2.50% to Rs 1277.65 after the company announced the successful completion of the United States Food and Drug Administration (US FDA) inspection for its oncology formulation facility located at Panelav, Gujarat.
KPIT Technologies hikes stake in N-Dream AG (09-10-2024)
The additional stake was acquired for a cash consideration of Euro 2.3 million in primary investment and Euro 0.7 million in secondary investment.
Lt foods (daawat) (09-10-2024)
And for “Resolution 5: To increase remuneration of Mr. Ritesh Arora, CEO- India & Far East Business, of the Company.” as well, 85% of institution voted against. And since promoter group’s vote is nil, the total vote against is ~40%.
Alembic Pharma’s oncology formulations unit successfully completes USFDA inspection (09-10-2024)
Powered by Capital Market – Live News